Concepedia

Author

A. Balil

Austrian Breast & Colorectal Cancer Study Group

Also Known As

A Balil, A. Balil, Ana Balil, Anna Balil

22

Publications

992

Citations

9

H-Index

15

Concepts

All Affiliations

Austrian Breast & Colorectal Cancer Study GroupBreast Cancer TrialsClínica Las CondesCancer Trials IrelandHospital Clínico San Carlos
AB

About

A. Balil is an author at Austrian Breast & Colorectal Cancer Study Group specializing in breast cancer, cancer therapeutics, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

230

2

Cancer Therapeutics

3

3

230

3

Health Sciences

2

2

44

4

Pharmacology

2

2

210

5

Pathology

1

1

20

A. Balil

×

9

Publications

982

Citations

9

H-Index

YearCitations

Risk-Adapted Management for Patients With Clinical Stage I Seminoma: The Second Spanish Germ Cell Cancer Cooperative Group Study

Jorge Aparicio, J.R. Germà, Xavier García del Muro,

Journal of Clinical Oncology

2005

231

Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial

Miguel Martín, Monserrat Muñoz, A. Balil,

The Lancet Oncology

2007

186

Adjuvant Chemotherapy With Sequential or Concurrent Anthracycline and Docetaxel: Breast International Group 02 98 Randomized Trial

Prudence A. Francis, John Crown, Angelo Di Leo,

JNCI Journal of the National Cancer Institute

2008

149

Multicenter Randomized Trial Comparing Sequential With Concomitant Administration of Doxorubicin and Docetaxel As First-Line Treatment of Metastatic Breast Cancer: A Spanish Breast Cancer Research Group (GEICAM-9903) Phase III Study

Emilio Alba, Miguel Martín, Manuel Ramos,

Journal of Clinical Oncology

2004

128

Randomized Clinical Trial of Adjuvant Mitomycin Plus Tegafur in Patients With Resected Stage III Gastric Cancer

Luis Cirera, A. Balil, E. Batiste-Alentorn,

Journal of Clinical Oncology

1999

115

Epirubicin–cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently versus sequentially: randomized phase III trial in postmenopausal node-positive breast cancer patients. A GEICAM 9401 study

Cesar Pico, Miguel Martín, Carlos Jara,

Annals of Oncology

2003

84

[Unilateral exophthalmos secondary to orbital metastasis as initial manifestation of breast cancer].

J.M. Porcel, Antonieta Salud, A. Balil

PubMed

2002

45

Docetaxel (T) given concurrently with or sequentially to anthracycline-based (A) adjuvant therapy (adjRx) for patients (pts) with node-positive (N+) breast cancer (BrCa), in comparison with non-T adjRx: First results of the BIG 2–98 Trial at 5 years median follow-up (MFU)

John Crown, Prudence A. Francis, Angelo Di Leo,

Journal of Clinical Oncology

2006

24

Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup phase III BIG 02-98 trial

Bernhard C. Pestalozzi, Prudence A. Francis, Emmanuel Quinaux,

Annals of Oncology

2008

20

Page 1